Related Experiment Video
Updated: Dec 30, 2025
08:18
Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
28.6K
Smad2 linker region phosphorylation is an autonomous cell signalling pathway: Implications for multiple disease
Danielle Kamato1, Peter J Little1
1Department of Pharmacy, Xinhua College of Sun Yat-sen University, Tianhe District, Guangzhou, 510520, China; School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Woolloongabba, Queensland, 4102, Australia.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 26, 2020
Summary
This review explores Smad linker region phosphorylation, a distinct signaling pathway. Understanding this pathway offers new drug targets for fibrosis, cancer, and cardiovascular diseases.
Area of Science:
- Molecular Biology
- Cell Signaling
- Drug Discovery
Background:
- Smad proteins are key mediators of Transforming Growth Factor-beta (TGF-β) signaling.
- Smad phosphorylation, particularly in the linker region, is crucial for signal transduction.
- Existing research often focuses on Smad carboxy-terminal phosphorylation, potentially overlooking other regulatory mechanisms.
Purpose of the Study:
- To review signaling pathways leading to Smad linker region phosphorylation independently of Smad carboxy-terminal phosphorylation.
- To establish the Smad linker region as a distinct signaling pathway for focused study.
- To identify novel drug targets involved in diseases like fibrosis, cancer, and cardiovascular conditions.
Main Methods:
- Literature review of signaling pathways.
- Analysis of Smad protein phosphorylation mechanisms.
- Comparative study of Smad signaling distinct from canonical TGF-β pathways.
Main Results:
- Identification of signaling pathways regulating Smad linker region phosphorylation independent of C-terminal phosphorylation.
- Characterization of the Smad linker region as a unique signaling entity.
- Highlighting the involvement of these pathways in significant disease pathologies.
Conclusions:
- The Smad linker region represents a critical, yet understudied, signaling hub.
- Further investigation into Smad linker phosphorylation can uncover novel therapeutic strategies.
- Targeting these distinct Smad pathways holds promise for treating fibrosis, cancer, and cardiovascular diseases.
Related Concept Videos
01:19Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
03:03mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
01:22PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
01:20The JAK-STAT Signaling Pathway
11.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.6K
01:22Amplifying Signals via Enzymatic Cascade
16.8K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.8K
01:07MAPK Signaling Cascades
7.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K